Eagle Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,867
| Closed | -$21K | – | 691 |
|
|
2020
Q4 | $21K | Buy |
+3,867
| New | +$21K | ﹤0.01% | 556 |
|
|
2019
Q4 | – | Sell |
-2,334,861
| Closed | -$12M | – | 662 |
|
|
2019
Q3 | $12M | Sell |
2,334,861
-438,790
| -16% | -$2.25M | 0.06% | 281 |
|
|
2019
Q2 | $19.9M | Sell |
2,773,651
-237,972
| -8% | -$1.7M | 0.1% | 232 |
|
|
2019
Q1 | $40M | Buy |
3,011,623
+158,650
| +6% | +$2.11M | 0.21% | 181 |
|
|
2018
Q4 | $22.5M | Buy |
2,852,973
+8,207
| +0.3% | +$64.6K | 0.14% | 212 |
|
|
2018
Q3 | $31.5M | Buy |
2,844,766
+781,700
| +38% | +$8.66M | 0.15% | 210 |
|
|
2018
Q2 | $27.7M | Buy |
+2,063,066
| New | +$27.7M | 0.15% | 211 |
|